PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

The mineralocorticoid receptor (MR) antagonists PF 03882845 and eplerenone were evaluated for renal protection against aldosterone mediated renal disease in uninephrectomized Sprague Dawley (SD) rats maintained on a high salt diet and receiving aldosterone by osmotic mini pump for 27 days. Serum K+...

Full description

Bibliographic Details
Main Authors: Stephen eOrena, Tristan eMaurer, Rena eEudy, Li eShe, Darla eDash, Paula eLoria, Mary Ellen eBanker, Vincent eBernardo, Meera eTugnait, Carlin eOkerberg, Jessie eQian, Carine M Boustany-Kari
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-10-01
Series:Frontiers in Pharmacology
Subjects:
Albuminuria
Aldosterone
Hyperkalemia
Chronic Kidney Disease
mineralocorticoid receptor
diabetic nephropathy
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00115/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00115/full

Similar Items